TAp73 transcriptionally represses BNIP3 expression

19Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

TAp73 is a tumor suppressor transcriptional factor, belonging to p53 family. Alteration of TAp73 in tumors might lead to reduced DNA damage response, cell cycle arrest and apoptosis. Carcinogen-induced TAp73−/− tumors display also increased angiogenesis, associated to hyperactivition of hypoxia inducible factor signaling. Here, we show that TAp73 suppresses BNIP3 expression, directly binding its gene promoter. BNIP3 is a hypoxia responsive protein, involved in a variety of cellular processes, such as autophagy, mitophagy, apoptosis and necrotic-like cell death. Therefore, through different cellular process altered expression of BNIP3 may differently contribute to cancer development and progression. We found a significant upregulation of BNIP3 in human lung cancer datasets, and we identified a direct association between BNIP3 expression and survival rate of lung cancer patients. Our data therefore provide a novel transcriptional target of TAp73, associated to its antagonistic role on HIF signaling in cancer, which might play a role in tumor suppression.

Author supplied keywords

Cite

CITATION STYLE

APA

Petrova, V., Mancini, M., Agostini, M., Knight, R. A., Annicchiarico-Petruzzelli, M., Barlev, N. A., … Amelio, I. (2015). TAp73 transcriptionally represses BNIP3 expression. Cell Cycle, 14(15), 2484–2493. https://doi.org/10.1080/15384101.2015.1044178

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free